EKF Diagnostics HoldingsLSE:EKF 52 Days Payable is 47.67 as of Dec. 2025, which is 109% above its 10-year median of 22.84. GuruFocus rates LSE:EKF with a GF Score™ of 52/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks worse than 78.74% on this metric.
The historical rank and industry rank for EKF Diagnostics Holdings's Days Payable or its related term are showing as below:
LSE:EKF'
s Days Payable Range Over the Past 10 Years
Min: 11.98 Med: 22.84 Max: 36.08
Current: 36.08
During the past 13 years, EKF Diagnostics Holdings's highest Days Payable was 36.08. The lowest was 11.98. And the median was 22.84.
LSE:EKF's Days Payable is ranked worse than 78.74% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs LSE:EKF: 36.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
EKF Diagnostics Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a Days Payable of 47.67 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EKF Diagnostics Holdings and its competitors. This is 109% above median its historical median of 22.84. Over the past decade, EKF Diagnostics Holdings' Days Payable has ranged from 11.98 to 36.08. According to the industry distribution chart, EKF Diagnostics Holdings ranks #626 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 78.7%.
Is EKF Diagnostics Holdings' Days Payable too high?
EKF Diagnostics Holdings' current Days Payable of 47.67 is 109% above median its 10-year median of 22.84. Over the past 10 years, this metric has ranged from a low of 11.98 to a high of 36.08. The Medical Devices & Instruments industry median Days Payable is 68.07. EKF Diagnostics Holdings' value of 47.67 is 30% below this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #626 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #626 out of 795 companies for Days Payable. This places EKF Diagnostics Holdings in the lower half of its industry. The industry median Days Payable is 68.07. EKF Diagnostics Holdings' value of 47.67 is 30% below this benchmark. Historically, EKF Diagnostics Holdings' own Days Payable has ranged from 11.98 to 36.08 over the past decade. While the company's 10-year median is 22.84 vs. the industry median of 68.07, EKF Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current Days Payable of 47.67 is 30% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Days Payable is 47.67, which is 109% above median its own 10-year median of 22.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 6.1% below its estimated fair value. The current Days Payable is 47.67, which is 109% above median its 10-year median of 22.84 and 30% below the Medical Devices & Instruments industry median of 68.07. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Days Payable is 47.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.26 is trading 6.1% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Days Payable: 47.67 (109% above median its 10-year median of 22.84)
GF Value™: £0.28 vs. price of £0.26 (6.1% below fair value)
Industry Position: 30% below the Medical Devices & Instruments median (#626 of 795)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
